库欣综合征患者即使长期缓解后骨材料强度指数仍偏低
本研究为横断面研究,纳入60例缓解期库欣综合征患者与60例年龄、性别及骨密度匹配的对照,采用冲击微压痕法测量胫骨骨材料强度指数。结果显示患者骨材料强度指数显著低于对照(76.2 ± 6.7 对 80.5 ± 4.9,P < .001),提示即使长期缓解,骨材料特性仍异常。
要点
- 缓解期库欣综合征患者骨材料强度指数低于骨密度匹配的对照。
- 患者与对照的骨密度及脆性骨折数量无显著差异。
- 患者骨材料强度指数与体重指数呈负相关,与骨折、氢化可的松替代等因素无关。
核心结论
- 内源性库欣综合征患者即使长期缓解后,骨材料特性仍存在异常,这些异常可能参与类固醇过多所致持续骨脆性的发生。
研究设计与样本
- 横断面研究,纳入60例库欣综合征患者和60例年龄、性别及骨密度匹配的对照,于2019年至2021年在一家三级转诊中心进行。
- 采用OsteoProbe®设备在胫骨处通过冲击微压痕法测量骨材料强度指数,并进行实验室检查、骨密度和椎体骨折评估。
主要发现
- 患者与对照的年龄(中位年龄56.5岁)、性别(48名女性)及腰椎和股骨颈骨密度均匹配。
- 患者与对照的脆性骨折数量分别为21例和27例,差异无统计学意义(P = .22)。
- 患者的中位缓解时间为6年(范围1至41年)。
- 尽管骨密度匹配,库欣综合征患者的骨材料强度指数显著低于对照(76.2 ± 6.7 对 80.5 ± 4.9,P < .001)。
- 在库欣综合征患者中,骨材料强度指数与体重指数呈负相关(r = -0.354,P = .01),但与骨折存在、生理性氢化可的松替代使用、其他垂体功能不全或缓解后时间无关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Hypercortisolism in endogenous Cushing's syndrome (CS) results in decreased bone mineral density (BMD) and increased fracture risk. Although after remission BMD improves, the fracture rate remains elevated, suggesting that BMD may not adequately reflect fracture risk in this group. The aim was to evaluate bone material properties, another component of bone quality, using impact microindentation in patients with CS in remission. METHODS: Cross-sectional study in 60 CS patients and 60 age-, sex-, and BMD-matched controls at a tertiary referral center between 2019 and 2021. Bone material strength index (BMSi) was measured by impact microindentation using the OsteoProbe® device at the tibia. In addition, laboratory investigation, BMD, and vertebral fracture assessment were performed. RESULTS: By design, patients and controls were comparable for age (median age 56.5 years), sex (48 women), and BMD at the lumbar spine and femoral neck. They were also comparable regarding the number of fragility fractures (21 vs 27, P = .22). The median time of remission in patients was 6 years (range 1 to 41). Despite comparable BMD, BMSi was significantly lower in CS patients compared to controls (76.2 ± 6.7 vs 80.5 ± 4.9, P < .001). In CS patients, BMSi was negatively correlated with body mass index (r = -0.354, P = .01) but not related to the presence of fracture, physiological hydrocortisone replacement use, other pituitary insufficiencies, or time since remission. CONCLUSION: Bone material properties remain altered in patients with endogenous CS, even after long-term remission. These abnormalities, known to be associated with fractures in other populations, may play a role in the persistent bone fragility of steroid excess.
引用
- Schoeb M, Sintenie PJC, Bakker LEH, et al. Bone Material Strength Index Is Low in Patients With Cushing's Syndrome Even After Long-term Remission. J Clin Endocrinol Metab. 2025. PMID: 39562003. doi:10.1210/clinem/dgae799
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。